$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-K Financial Statement

#000109181815000005 Filed on January 13, 2015

Income Statement

Concept	2014 Q4	2014 Q3	2014
Revenue	$72.08K	$50.00K	$207.4K
YoY Change	34.84%	-58.33%	-51.46%
Cost Of Revenue	$37.51K	$20.00K	$92.35K
YoY Change	62.68%	-71.43%	-62.91%
Gross Profit	$34.57K	$30.00K	$115.1K
YoY Change	13.73%	-40.0%	-35.46%
Gross Profit Margin	47.96%	60.0%	55.48%
Selling, General & Admin	$91.30K	$80.00K	$333.3K
YoY Change	-25.61%	-74.19%	-84.12%
% of Gross Profit	264.13%	266.67%	289.65%
Research & Development	$0.00	$0.00	$6.650K
YoY Change		-100.0%	-19.88%
% of Gross Profit	0.0%	0.0%	5.78%
Depreciation & Amortization		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit		0.0%	0.0%
Operating Expenses	$91.30K	$80.00K	$340.0K
YoY Change	-25.61%	-75.0%	-83.89%
Operating Profit	-$56.73K	-$50.00K	-$224.9K
YoY Change	-38.56%	-81.48%	-88.36%
Interest Expense	$18.96K	-$20.00K	$75.01K
YoY Change	1.28%	0.0%	-49.82%
% of Operating Profit
Other Income/Expense, Net	-$18.96K		-$75.01K
YoY Change	1.28%		-91.96%
Pretax Income	-$80.00K	-$60.00K	-$300.0K
YoY Change	-27.27%	-79.31%	-89.51%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$75.69K	-$60.00K	-$299.9K
YoY Change	-31.84%	-79.31%	-89.53%
Net Earnings / Revenue	-105.01%	-120.0%	-144.58%
Basic Earnings Per Share
Diluted Earnings Per Share	-$37.60	-$26.51	-$142.10
COMMON SHARES
Basic Shares Outstanding	2.132B shares	2.125B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2014
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Cash & Equivalents	$1.041K	$2.505K
Short-Term Investments
Other Short-Term Assets	$10.00K	$10.00K	$10.00K
YoY Change	-75.0%	-85.71%	-85.71%
Inventory	$11.12K	$16.09K	$20.00K
Prepaid Expenses
Receivables			$0.00
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$24.76K	$27.26K	$30.00K
YoY Change	-77.21%	-78.25%	-76.92%
LONG-TERM ASSETS
Property, Plant & Equipment			$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$24.76K	$27.26K	$30.00K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$24.76K	$27.26K	$30.00K
YoY Change	-77.21%	-78.25%	-76.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$391.4K	$387.6K	$390.0K
YoY Change	9.24%	-12.46%	-11.36%
Accrued Expenses	$298.0K	$286.0K	$290.0K
YoY Change	14.41%	20.82%	20.83%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$180.0K	$180.0K	$180.0K
YoY Change	0.0%	-45.45%	-45.45%
Total Short-Term Liabilities	$917.7K	$896.0K	$900.0K
YoY Change	8.6%	-15.08%	-15.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Total Long-Term Liabilities	$1.735K	$2.825K	$0.00
YoY Change	-82.65%	-73.61%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$917.7K	$896.0K	$900.0K
Total Long-Term Liabilities	$1.735K	$2.825K	$0.00
Total Liabilities	$919.4K	$898.8K	$900.0K
YoY Change	8.12%	-15.67%	-15.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.18M	-$12.10M
YoY Change	2.22%	2.54%
Common Stock	$21.32K	$21.25K
YoY Change	1.12%	3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$894.7K	-$871.6K	-$870.0K
YoY Change
Total Liabilities & Shareholders Equity	$24.76K	$27.26K	$30.00K
YoY Change	-77.21%	-78.22%	-76.92%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2014
OPERATING ACTIVITIES
Net Income	-$75.69K	-$60.00K	-$299.9K
YoY Change	-31.84%	-79.31%	-89.53%
Depreciation, Depletion And Amortization		$0.00	$0.00
YoY Change			-100.0%
Cash From Operating Activities	-$60.00K	-$10.00K	-$220.0K
YoY Change	-53.85%		100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$25.00K
YoY Change	-91.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.00K	0.000	210.0K
YoY Change	-60.0%	-100.0%	133.33%
NET CHANGE
Cash From Operating Activities	-60.00K	-10.00K	-220.0K
Cash From Investing Activities
Cash From Financing Activities	60.00K	0.000	210.0K
Net Change In Cash	0.000	-10.00K	-10.00K
YoY Change	-100.0%	-200.0%	-50.0%
FREE CASH FLOW
Cash From Operating Activities	-$60.00K	-$10.00K	-$220.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	11853275	shares
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	248994	USD
CY2014	us-gaap	Gross Profit GrossProfit	115075	USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00209
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2110696898	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1369700683	shares
CY2014	us-gaap	Revenues Revenues	207424	USD
CY2013	us-gaap	Revenues Revenues	427286	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	92349	USD
CY2013	us-gaap	Interest Expense InterestExpense	149500	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75014	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-933050	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-299899	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-2864429	USD
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00014
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18055	USD
CY2014	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument		USD
CY2013	us-gaap	Gain Loss On Repurchase Of Debt Instrument GainLossOnRepurchaseOfDebtInstrument	472127	USD
CY2014	clri	Gain Loss On Share Exchange GainLossOnShareExchange		USD
CY2013	clri	Gain Loss On Share Exchange GainLossOnShareExchange	-1273732	USD
CY2014	us-gaap	Interest Expense InterestExpense	75014	USD
CY2013	us-gaap	Depreciation Depreciation	2342	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	339960	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	2109671	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-224885	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-1931379	USD
CY2014	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	83832	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	302789	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2015197	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6650	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8300	USD
CY2014	us-gaap	Depreciation Depreciation		USD
CY2013	us-gaap	Gross Profit GrossProfit	178292	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30521	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	623215	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-27232	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11188	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38420	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2505	USD
CY2014	us-gaap	Interest Paid InterestPaid	5895	USD
CY2013	us-gaap	Interest Paid InterestPaid	32806	USD
CY2013	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	196555	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	20000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	209000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	86555	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-8683	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-113787	USD
CY2014	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	359000	USD
CY2013	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	35000	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		USD
CY2013	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	125000	USD
CY2014	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	67965	USD
CY2014	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	2002	USD
CY2013	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	8428	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13071	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	22675	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-217683	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7186	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60001	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-55177	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23624	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	49270	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22404	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19936	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6787	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	51618	USD
CY2014	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet		USD
CY2013	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-1331	USD
CY2014	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims	10000	USD
CY2013	clri	Issuance Of Common Stock And Warrants For Services Or Claims IssuanceOfCommonStockAndWarrantsForServicesOrClaims	1801859	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	668251	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	-871558	USD
CY2014	clri	Common Stock Issued In Conversion Of Preferredc Shares CommonStockIssuedInConversionOfPreferredcShares		USD
CY2014	clri	Common Stock Issued In Conversion Of Preferreda Shares CommonStockIssuedInConversionOfPreferredaShares		USD
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	10000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	359000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-940659	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	64553	USD
CY2013	clri	Common Stock Issued In Conversion Of Preferredc Shares CommonStockIssuedInConversionOfPreferredcShares		USD
CY2013	clri	Common Stock Issued In Conversion Of Preferreda Shares CommonStockIssuedInConversionOfPreferredaShares		USD
CY2013	clri	Preferred Stock Issued In Exchange For Cancellation Of Options And Warrants PreferredStockIssuedInExchangeForCancellationOfOptionsAndWarrants	13330	USD
CY2013	clri	Shares Cancelled In Exchange For Preferred Shares Value SharesCancelledInExchangeForPreferredSharesValue	1265959	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	909000	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	670248	USD
CY2013	clri	Shares Issued For Conversion Of Accounts Payable SharesIssuedForConversionOfAccountsPayable	265672	USD
CY2013	clri	Shares Issued For Conversion Of Convertible Debt And Derivative Liability SharesIssuedForConversionOfConvertibleDebtAndDerivativeLiability	22221	USD
CY2013	clri	Shares Issued For Conversion Of Notes Payables And Accrued Interest SharesIssuedForConversionOfNotesPayablesAndAccruedInterest	41961	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	35000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	-1364174	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		USD
CY2014	clri	Effective Income Tax Rate For Deferred Tax Asset EffectiveIncomeTaxRateForDeferredTaxAsset	0.390	pure
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	136125	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	136125	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	136125	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	136125	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		USD
CY2013	clri	Effective Income Tax Rate For Deferred Tax Asset EffectiveIncomeTaxRateForDeferredTaxAsset	0.390	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.390	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.390	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2014Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0.00	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0.00	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050	pure
CY2013Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4400000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4520000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4400000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4520000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4520000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4400000	USD
CY2014Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11584000	USD
CY2013Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11284000	USD
CY2014	clri	Annual Increase To Base Rent AnnualIncreaseToBaseRent	0.04	pure
CY2014	clri	Amount Rent Was Reduced Due To Sublease Agreement AmountRentWasReducedDueToSubleaseAgreement	30000	USD
CY2014	clri	Number Of Manufacturing Facilites Under Contract NumberOfManufacturingFacilitesUnderContract	1	pure
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	43560	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	166340	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	51549	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	56212	USD
CY2013	clri	Amount Rent Was Reduced Due To Sublease Agreement AmountRentWasReducedDueToSubleaseAgreement	26000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	40640	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	41260	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	41880	USD
CY2014	clri	Area Of Leased Facility AreaOfLeasedFacility	1700
CY2014	clri	Monthly Rental Cost MonthlyRentalCost	3200	USD
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2183	shares
CY2012Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	189.00
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	399	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	135.00
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1784	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	196.00
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	167	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	90.00
CY2013Q3	us-gaap	Liabilities Liabilities	1065789	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		USD
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8656	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68657	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	27255	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	125310	USD
CY2014Q3	us-gaap	Assets Assets	27255	USD
CY2013Q3	us-gaap	Assets Assets	125310	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	387575	USD
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1617	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	196.00
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	442752	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	285950	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	236680	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31295	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	36487	USD
CY2014Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	10430	USD
CY2013Q3	us-gaap	Customer Deposits Current CustomerDepositsCurrent	8428	USD
CY2014Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	180738	USD
CY2013Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	330738	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	895988	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1055085	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2825	USD
CY2013Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	10704	USD
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2124900908	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2058069648	shares
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	clri	Receivables Factoring Discount Rate Lower Range ReceivablesFactoringDiscountRateLowerRange	0.0225	pure
CY2014Q3	clri	Receivables Factoring Discount Rate Higher Range ReceivablesFactoringDiscountRateHigherRange	0.0625	pure
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2014Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2014Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2825	USD
CY2013Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10704	USD
CY2014Q3	us-gaap	Liabilities Liabilities	898813	USD
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2124900908	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2058069648	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	21249	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	20581	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11208314	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10839980	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12101150	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11801251	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22404	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27255	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125130	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	16094	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	22881	USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3200	USD
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	12609535	shares
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2013	us-gaap	Inventory Write Down InventoryWriteDown	5000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	2121	USD
CY2013	us-gaap	Advertising Expense AdvertisingExpense	2458	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p align="justify" style=" line-height: 14pt; margin: 0pt; padding-left: 63.35pt; font-family: Arial; font-size: 12pt;"><font style=" font-size: 10pt;">USE OF ESTIMATES</font></p> <p align="justify" style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"> </font></p> <p align="justify" style=" line-height: 14pt; margin: 0pt; padding-left: 63.7pt; font-family: Arial; font-size: 12pt;"><font style=" font-size: 10pt;">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</font></p> </div>
CY2014	us-gaap	Concentration Risk Credit Risk Uninsured Deposits ConcentrationRiskCreditRiskUninsuredDeposits	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p align="justify" style=" line-height: 14pt; margin: 0pt; text-indent: 63.7pt; font-family: Arial; font-size: 12pt;"><font style=" font-size: 10pt;">CONCENTRATION OF CREDIT RISK</font></p> <p align="justify" style=" margin: 0pt; font-family : Times New Roman;"><font style=" font-size: 10pt;"> </font></p> <p align="justify" style=" line-height: 14pt; margin: 0pt; padding-left: 63.35pt; font-family: Arial; font-size: 12pt;"><font style=" font-size: 10pt;">The Company currently maintains cash balances at </font><font><font style=" font-size: 10pt;">one</font></font><font style=" font-size: 10pt;"> FDIC-insured banking institution. Deposits held in noninterest-bearing transaction accounts are insured up to a maximum of $</font><font><font style=" font-size: 10pt;">250,000</font></font><font style=" font-size: 10pt;"> at all FDIC-insured institutions.</font></p> </div>
CY2014	clri	Period For Which Federal And State Income Tax Returns Are Subject To Examination By Irs And State Taxing Authorities PeriodForWhichFederalAndStateIncomeTaxReturnsAreSubjectToExaminationByIRSAndStateTaxingAuthorities	P3Y
CY2012	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	3000 to 1
CY2014Q1	dei	Entity Public Float EntityPublicFloat	19180053	USD
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2131812230	shares
CY2014	us-gaap	Increase Decrease In Other Loans IncreaseDecreaseInOtherLoans	869000	USD
CY2012Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	27500	shares
CY2012Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	22221	USD
CY2012Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	12842	USD
CY2013Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	125000	USD
CY2013Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	123000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	65000	USD
CY2012Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	7700	USD
CY2014Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2014Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	Cleartronic, Inc.
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY

Files In Submission

Name	View Source	Status
0001091818-15-000005-index-headers.html	Edgar Link	pending
0001091818-15-000005-index.html	Edgar Link	pending
0001091818-15-000005.txt	Edgar Link	pending
0001091818-15-000005-xbrl.zip	Edgar Link	pending
clri-20140930.xml	Edgar Link	completed
clri-20140930.xsd	Edgar Link	pending
clri-20140930_cal.xml	Edgar Link	unprocessable
clri-20140930_def.xml	Edgar Link	unprocessable
clri-20140930_lab.xml	Edgar Link	unprocessable
clri-20140930_pre.xml	Edgar Link	unprocessable
clri0107201510k.htm	Edgar Link	pending
ex1010.htm	Edgar Link	pending
ex108.htm	Edgar Link	pending
ex109.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2014 Q4 Form 10-K Financial Statement

#000109181815000005 Filed on January 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2014 Q4 Form 10-K Financial Statement

#000109181815000005 Filed on January 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri